CD8A and COVID-19: In COVID-19 patients, Shahbaz et al. found an overexpression of 2B4 on peripheral blood CD4+ and CD8+ T cells; however, CD160 was upregulated on CD4+ T cells but not on CD8+ T cells, compared with controls (40).